Status:
RECRUITING
Prevention of Developmental Delay and Xylitol (PDDaX) Study
Lead Sponsor:
University of Washington
Conditions:
Prematurity
Neurodevelopmental Disorders
Eligibility:
All Genders
4-8 years
Phase:
NA
Brief Summary
The goals of this study are to: evaluate and validate the low-cost, transportable, easily-administered Malawi Developmental Assessment Tool (MDAT) for neurodevelopmental assessment of children aged 4-...
Eligibility Criteria
Inclusion
- Child born during the PPaX trial
- Enrollment age between 4-8 years old
- Parental or legal guardian consent obtained
- Willing to undergo 3 neurodevelopmental tests
- Willing to travel to BCMF for neurodevelopmental assessment
- Assent by the pediatric subject for participation in the study
Exclusion
- Parent or legal guardian cognitively unable to provide consent
- Child unwilling to provide assent to participate in the study
Key Trial Info
Start Date :
April 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05361122
Start Date
April 4 2023
End Date
August 31 2027
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine Children's Foundation-Malawi
Lilongwe, Malawi